Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
3.300
-0.060 (-1.79%)
At close: Oct 30, 2026, 4:00 PM EDT
3.320
+0.020 (0.61%)
After-hours: Oct 30, 2026, 7:32 PM EDT
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $1.22 billion as of October 30, 2026. Its market cap has increased by 29.50% in one year.
Market Cap
1.22B
Enterprise Value
459.64M
1-Year Change
29.50%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since February 27, 2018, Cronos Group's market cap has increased from $1.14B to $1.22B, an increase of 7.19%. That is a compound annual growth rate of 0.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.22B | 21.14% |
| Dec 31, 2025 | 1.01B | 30.41% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioCryst Pharmaceuticals | 2.18B |
| Trulieve Cannabis | 2.04B |
| Xeris Biopharma Holdings | 1.96B |
| Alvotech | 1.75B |
| Phibro Animal Health | 1.58B |
| ANI Pharmaceuticals | 1.57B |
| Eton Pharmaceuticals | 1.53B |
| Pacira BioSciences | 1.45B |